IRIS Accounts Production v24.3.2.46 05768239 Board of Directors 1.5.23 30.4.24 30.4.24 30.1.25 0 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057682392023-04-30057682392024-04-30057682392023-05-012024-04-30057682392022-04-30057682392022-05-012023-04-30057682392023-04-3005768239ns15:EnglandWales2023-05-012024-04-3005768239ns14:PoundSterling2023-05-012024-04-3005768239ns10:Director12023-05-012024-04-3005768239ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3005768239ns10:SmallEntities2023-05-012024-04-3005768239ns10:Audited2023-05-012024-04-3005768239ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3005768239ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3005768239ns10:FullAccounts2023-05-012024-04-3005768239ns10:Director32023-05-012024-04-3005768239ns10:RegisteredOffice2023-05-012024-04-3005768239ns5:CurrentFinancialInstruments2024-04-3005768239ns5:CurrentFinancialInstruments2023-04-3005768239ns5:Non-currentFinancialInstruments2024-04-3005768239ns5:Non-currentFinancialInstruments2023-04-3005768239ns5:ShareCapital2024-04-3005768239ns5:ShareCapital2023-04-3005768239ns5:RetainedEarningsAccumulatedLosses2024-04-3005768239ns5:RetainedEarningsAccumulatedLosses2023-04-3005768239ns5:PlantMachinery2023-04-3005768239ns5:PlantMachinery2023-05-012024-04-3005768239ns5:PlantMachinery2024-04-3005768239ns5:PlantMachinery2023-04-3005768239ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3005768239ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-30
REGISTERED NUMBER: 05768239 (England and Wales)















ALBA PROTEINS PENRITH LIMITED

AUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 APRIL 2024






ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALBA PROTEINS PENRITH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: D S Sawrij
L J Savry





REGISTERED OFFICE: Swales Moor Farm
Swales Moor Road
Halifax
West Yorkshire
HX3 6UF





REGISTERED NUMBER: 05768239 (England and Wales)





AUDITORS: Xeinadin Audit Limited
Sidings House
Sidings Court
Lakeside
Doncaster
South Yorkshire
DN4 5NU

ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 13,170,064 9,206,259

CURRENT ASSETS
Debtors 5 1,858,217 3,105,578
Cash at bank 53,448 51,299
1,911,665 3,156,877
CREDITORS
Amounts falling due within one year 6 4,860,345 1,105,887
NET CURRENT (LIABILITIES)/ASSETS (2,948,680 ) 2,050,990
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,221,384

11,257,249

CREDITORS
Amounts falling due after more than one
year

7

(3,758,956

)

(4,947,751

)

PROVISIONS FOR LIABILITIES (1,236,397 ) (869,477 )
NET ASSETS 5,226,031 5,440,021

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 5,226,030 5,440,020
5,226,031 5,440,021

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 January 2025 and were signed on its behalf by:





D S Sawrij - Director


ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024


1. STATUTORY INFORMATION

The legal form of the entity is that of a private limited company limited by shares.

The Company is incorporated in England and Wales. The address of its registered office is included on the Company information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before the revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
- the Company has transferred the significant risks and rewards of ownership to the buyer;
- the Company retains neither continuing managerial involvement to the degree usually associated with
ownership nor effective control over the goods sold;
- the amount of revenue can be measured reliably;
- it is probable that the Company will receive the consideration due under the transaction; and
- the costs incurred or to be incurred in respect of the transaction can be measured reliably

ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


2. ACCOUNTING POLICIES - continued

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Comprehensive Income except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Statement of Comprehensive Income within 'other operating income'.

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Assets are being depreciated straight line over 20 years.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Current and deferred taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Short term debtors are measured at transaction price, less any impairments. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

Provisions are charges as an expense to the Statement of Comprehensive Income in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the Statement of Financial Position date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the Statement of Financial Position.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - NIL ) .

ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 9,206,259
Additions 4,301,499
At 30 April 2024 13,507,758
DEPRECIATION
Charge for year 337,694
At 30 April 2024 337,694
NET BOOK VALUE
At 30 April 2024 13,170,064
At 30 April 2023 9,206,259

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors - 105,537
Amounts owed by group undertakings 998,870 3,000,041
Other debtors 859,347 -
1,858,217 3,105,578

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 1,072,400 1,102,227
Amounts owed to group undertakings 3,678,887 -
Taxation and social security 6,227 80
Other creditors 102,831 3,580
4,860,345 1,105,887

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Hire purchase contracts 3,758,956 4,947,751

ALBA PROTEINS PENRITH LIMITED (REGISTERED NUMBER: 05768239)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


8. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Hire purchase contracts 4,831,356 6,049,978

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Kelvin Fitton BA FCA (Senior Statutory Auditor)
for and on behalf of Xeinadin Audit Limited

10. PENSION COMMITMENTS

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £609 (2023: £Nil). Contributions totalling £593 (2023: £Nil) were payable to the fund at the balance sheet date.

11. ULTIMATE CONTROLLING PARTY

The company's immediate parent company is Leo Group Holdings Midco Limited, a company registered in Jersey, and the ultimate parent company is Leo Group Family Holdings Limited, also registered in Jersey. The ultimate controlling party is Mr D S Sawrij.